Emtricitabine/Tenofovir Disoproxil Tillomed

Emtricitabine/Tenofovir Disoproxil Tillomed is a combination medication used for HIV treatment and prevention. This oral medication is designed to help manage HIV infection and reduce the risk of transmission.

Emtricitabine/Tenofovir Disoproxil Tillomed is primarily used in the treatment of HIV-1 infection in adults and adolescents. It is also used for pre-exposure prophylaxis (PrEP) to prevent HIV infection in individuals at high risk. This medication works by reducing the amount of HIV in the body, helping to improve immune function and lower the risk of HIV-related complications.

Common effects of Emtricitabine/Tenofovir Disoproxil Tillomed may include headache, nausea, diarrhea, and fatigue. Some individuals may experience dizziness, rash, or changes in mood. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Emtricitabine/Tenofovir Disoproxil Tillomed should be used with caution in individuals with kidney problems or a history of bone disorders. Regular monitoring of kidney function and bone density may be recommended. It is important to follow the prescribed dosage and not to share this medication with others.

Emtricitabine/Tenofovir Disoproxil Tillomed may interact with other medications, including certain antibiotics, antifungals, and HIV medications. Alcohol consumption should be moderated, as it may exacerbate side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.